| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.29M | 912.00K | 0.00 | 0.00 | 1.75M | 351.49K |
| Gross Profit | -352.00K | 241.00K | -700.00K | -463.00K | -308.00K | 351.49K |
| EBITDA | -5.47M | -5.38M | -8.86M | -8.99M | -10.49M | -1.53M |
| Net Income | -5.98M | -5.98M | -7.95M | -7.41M | -13.81M | -1.80M |
Balance Sheet | ||||||
| Total Assets | 11.36M | 11.36M | 13.59M | 13.69M | 20.61M | 4.03M |
| Cash, Cash Equivalents and Short-Term Investments | 2.66M | 2.66M | 3.79M | 7.27M | 17.04M | 1.91M |
| Total Debt | 27.00K | 27.00K | 8.00K | 26.00K | 56.00K | 122.02K |
| Total Liabilities | 1.39M | 1.39M | 1.63M | 1.08M | 12.08M | 442.18K |
| Stockholders Equity | 9.97M | 9.97M | 11.97M | 12.60M | 19.72M | 3.59M |
Cash Flow | ||||||
| Free Cash Flow | -4.57M | -4.94M | -5.96M | -10.47M | -5.31M | -1.66M |
| Operating Cash Flow | -4.41M | -4.46M | -4.53M | -6.03M | -4.53M | -1.27M |
| Investing Cash Flow | -481.00K | -435.00K | -2.63M | -2.09M | -1.80M | -379.33K |
| Financing Cash Flow | 3.95M | 3.95M | 3.71M | -28.00K | 20.55M | -125.88K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £810.84M | 18.62 | 15.54% | 1.11% | 8.20% | 25.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | £347.34M | -21.90 | -8.12% | ― | -18.43% | 24.86% | |
56 Neutral | £579.07M | -16.30 | -23.26% | ― | 12.58% | 12.39% | |
51 Neutral | £132.56M | -5.11 | -86.37% | ― | 732.03% | 12.60% | |
46 Neutral | £43.59M | -4.66 | ― | ― | ― | ― | |
44 Neutral | £56.06M | -7.31 | -31.45% | ― | 265.67% | -16.50% |
Gelion plc has reported its latest block admission return for its existing share option plan for the period from 26 July 2025 to 26 January 2026. Over the period, 69,673 ordinary shares of 0.1p each were issued under the plan, leaving 7,803,267 ordinary shares still available but not yet issued out of the 8,100,000 originally admitted, indicating only a modest level of option exercises and limited dilution for existing shareholders during the half-year.
The most recent analyst rating on (GB:GELN) stock is a Hold with a £19.50 price target. To see the full list of analyst forecasts on Gelion PLC stock, see the GB:GELN Stock Forecast page.
Gelion has appointed world-renowned battery scientist Professor Rachid Yazami as a Technology Advisor to support its push into sulfur battery innovation, particularly the development of a sulfur cathode designed as a drop-in alternative to standard lithium-ion cathode materials in LFP and NMC cells. The appointment brings to Gelion the expertise of the pioneer behind the lithium-graphite anode now standard in commercial lithium-ion batteries, reinforcing its plans to pair its sulfur cathodes with conventional graphitic anodes and strengthening its technological leadership in the emerging Li-S segment, which is touted for cost-effective, high-energy-density and safe energy storage and could enhance the company’s position in the rapidly evolving energy storage market.
The most recent analyst rating on (GB:GELN) stock is a Hold with a £21.50 price target. To see the full list of analyst forecasts on Gelion PLC stock, see the GB:GELN Stock Forecast page.
Gelion PLC has confirmed that, following the exercise of employee share options in December 2025, its issued share capital now comprises 229,421,456 ordinary shares of 0.1 pence each, all carrying equal voting rights and with no shares held in treasury. The updated share count establishes the new total voting rights in the company, providing the reference figure shareholders must use to assess whether they are required to disclose holdings or changes in their interests under the UK Disclosure Guidance and Transparency Rules.
Gelion plc disclosed that its chief financial officer, Amit Gupta, purchased 50,000 ordinary shares in the company on 23 December 2025 at 19 pence per share on the London Stock Exchange’s AIM market. Following this transaction, Gupta’s holding increased to 193,810 ordinary shares, representing approximately 0.084% of the company’s total voting rights, signalling increased insider ownership and potential confidence in Gelion’s prospects.
Gelion announced that all resolutions put to shareholders at its latest Annual General Meeting were duly passed, confirming continued investor backing for the company’s strategic direction and governance. The outcome reinforces management’s mandate to advance its portfolio of sulfur-based and zinc hybrid battery technologies and commercial energy storage projects, supporting its positioning as a specialist player in sustainable energy storage solutions.
Gelion PLC has announced the rebranding of its wholly-owned UK subsidiary, OXLiD Ltd, to Gelion Europe Ltd. This change marks the completion of the post-acquisition integration process and aims to consolidate the Gelion brand for global partners and stakeholders. The rebranding also signifies the successful incorporation of lithium-sulfur technology into Gelion’s energy storage portfolio and represents the company’s expanding European operations. The change is expected to enhance engagement with supply chains and commercial partners, reflecting Gelion’s commitment to advancing sulfur battery technologies globally.
Gelion PLC has announced the grant of 284,015 share options to Amit Gupta, the Chief Financial Officer, as part of the company’s Share Option Plan. This move is in recognition of his contributions during the fiscal year 2025 and aligns with the company’s strategy to incentivize key executives. The options, which have a nominal exercise price, are set to vest in three equal tranches by August 2028, contingent upon continued employment. This grant reflects Gelion’s commitment to rewarding its leadership and could potentially impact the company’s market positioning by retaining key talent.
Gelion PLC has achieved a significant technical milestone by reaching the 4Q areal capacity in the development of its sulfur battery technology. This breakthrough demonstrates the potential of Gelion’s proprietary cathode active material (CAM) to produce high-energy-density, low-cost sulfur-based batteries suitable for various applications, including e-aviation and electric mobility. The achievement marks a critical step towards scaling sulfur-based technology for commercial-grade battery systems, enhancing Gelion’s competitiveness against conventional lithium-ion technology. The milestone supports Gelion’s energy-density and cost objectives, strengthening its roadmap for future high-energy-density battery targets.
Gelion PLC has announced its Annual General Meeting (AGM) scheduled for 22 December 2025, which will be held at the company’s registered office in London. Shareholders can attend the meeting remotely by registering in advance. This announcement highlights Gelion’s ongoing commitment to engaging with its stakeholders and maintaining transparency in its operations, which is crucial for its positioning in the competitive energy storage industry.
Gelion PLC has reported its final results for the year ending June 30, 2025, marking a significant transition into a commercial revenue phase with a 36% increase in total income to £2.7 million. The company has made substantial progress in financial discipline and operational efficiency, reducing its adjusted EBITDA loss by 15% and narrowing its operating loss by 25.7%. Strategic collaborations with institutions like the Max Planck Institute and TDK Corporation have enhanced Gelion’s technological capabilities, particularly in sulfur and lithium recycling technologies. The company has achieved breakthroughs in its Sodium-Sulfur and Lithium-Sulfur battery technologies, delivering industry-leading performance. Post-period, Gelion has strengthened its balance sheet with a £10.5 million capital raise and signed a full collaboration agreement with TDK to develop commercial pouch cell prototypes, positioning itself for future growth and innovation in the energy storage sector.
Gelion PLC announced that it will release its full-year financial results for the year ending June 30, 2025, on November 27, 2025. The announcement will be accompanied by an investor presentation hosted by the company’s CEO, CFO, and CTO. This event highlights Gelion’s commitment to transparency and engagement with stakeholders, potentially impacting its market positioning positively by showcasing its financial health and strategic direction.
Gelion PLC announced the successful passing of all proposed resolutions at its recent General Meeting, leading to the issuance of 1,150,000 new shares subscribed by directors and PDMRs at 20 pence per share. The new shares will be admitted to trading on AIM, increasing the company’s total voting rights to 229,351,783, which may impact shareholder notifications under FCA rules.